reach study semaglutide Post hoc analysis of SUSTAIN 6 and PIONEER 6 trials suggests that people with type 2 diabetes at high cardiovascular risk treated with experience more stable kidney function compared with placebo Efficacy and safety of once-weekly

They may help improve cardiovascular health, fatty liver disease, and reduce the risk of heart disease

The Takeaway Weird-looking poop can point to colon cancer, especially if it is a change from your usual bowel movements and looks like pebbles or narrow ribbons, or if it contains blood

When paired with personalized lifestyle support, they encourage long-lasting results, making it easier to stay at a healthy weight and prevent future setbacks

As the use of One such area is eye health

Working with a healthcare provider experienced in peptide-based weight management helps navigate these decisions

In clinical trials of Wegovy (FDA-approved semaglutide), participants achieved an average weight loss of approximately 15% over 68 weeks, with some participants achieving up to 20% with continued treatment and adherence, when combined with diet and exercise